Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Diane Lorraine Borst"'
Autor:
Elizabeth A. MacLean, Lillian Shahied Arruda, James E. Morgado, Diane Lorraine Borst, Yazdi K. Pithavala
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 71(13)
Purpose An overview of the responses to some of the most frequently asked questions regarding axitinib administration and dosage modifications used in clinical practice are presented. Summary Axitinib was approved for second-line treatment of advance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::920e83194b7d2333c954829cacf78617
https://pubmed.ncbi.nlm.nih.gov/24939498
https://pubmed.ncbi.nlm.nih.gov/24939498
Autor:
Elizabeth A. MacLean, Nikhil Sharma, Diane Lorraine Borst, Lillian Shahied Arruda, James E. Morgado, Yazdi K. Pithavala
Publikováno v:
Journal of Clinical Oncology. 32:538-538
538 Background: Axitinib is a next generation VEGFR inhibitor approved in the US in Jan 2012 for advanced RCC after failure of one prior systemic therapy. Post approval questions may arise in the medical community regarding clinical scenarios which m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a18c47e330d2ee647424c06c887cef86
https://doi.org/10.1200/jco.2014.32.4_suppl.538
https://doi.org/10.1200/jco.2014.32.4_suppl.538